Sfoglia per AUTORE
FOWLER NH
Collezione AOU Città della Salute di Torino

  

Items : 2

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Aug 10;36(23):2405-2412. doi: 10.1200/JCO.2017.76.8853. Epub 2018 May 31.
2018
AOU Città della Salute di Torino

Salles G; Cheson BD; Vermeulen J; Balasubramanian S; Schaffer M; Damle RN; Wang SS; Gartenberg GJ; Deshpande S; Caballero D; Morton J; Jurczak W; Radford J; Spencer A; Vitolo U; Martin P; Lill M; Yacoub A; Hou JZ; Hess G; Trotman J; Fowler NH; Schuster SJ; Gopal AK; Gopal AK; Schuster SJ; Fowler NH; Trotman J; Hess G; et alii...

Thirty-Month Complete Response as a Surrogate End Point in First-Line Follicular Lymphoma Therapy: An Individual Patient-Level Analysis of Multiple Randomized Trials. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Feb 10;35(5):552-560. doi: 10.1200/JCO.2016.70.8651. Epub 2016 Dec 28.
2017
AOU Città della Salute di Torino

Sargent DJ; Salles G; Zucca E; Morschhauser F; Ladetto M; Hoster E; Fowler NH; Valente N; Fu T; De Bedout S; Nielsen T; Ghielmini M; Gyan E; Peterson BA; Vitolo U; Hochster H; Kimby E; Hagenbeek A; Herold M; Marcus R; Hiddemann W; Flowers CR; Shi Q;